Pharmaceuticals, Biotechnology and Life Sciences
Diaceutics data analytics shows 31% drop in the number of newly-diagnosed patients with lung cancer, with decrease in the number of colorectal, breast and ovarian cancers patients diagnosed, and 14% drop in newly-diagnosed patients with acute myeloid leukemia
FDA has approves Merck’s Keytruda, pembrolizumab, for use at an additional recommended dose of 400 mg every six weeks for all approved adult indications.
Incyte last week named new Canada Biosciencess head, announcing establishing key development and commercialization capabilities in preparation for potential launches of multiple products in the near future.
ValiRx got patent from the US Patent and Trademark Office for modulators Of the SRC-kinase activity for preventing or treating…
Tarveda Therapeutics said in a PR Friday that PEN-221 miniature drug conjugate allow for deep tumor penetration, while limiting plasma…
Tilray has imported medical cannabis to USA and Canada in support of a new trieal, first-of-its-kind, which will test the…
Amphivena is set to move on with AMV564 in a Multi-Center Dose Finding Phase 1 Clinical Study in Patients with…
NOXXON said Wednesday it has enrolled the first patient in phase 1/2 trial in a therapy of increasing doses of…
Komen vows to drive breakthroughs for the most-deadly breast cancers and educate those who believe breast cancers are easily treated…
Annie Martin, Global Head of Presicion Medicine, has discussed the future of targeted therapy and genomic profiling, describing how to…